Mejia, Miecel C.
HRN: 23-78-74 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/29/2023
CEFUROXIME 500MG (TAB)
09/29/2023
10/06/2023
PO
500mg
BID X 7 Days
S/P NSVD To A Stillborn
Checking Final Appropriateness
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes